Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115]
- RabMAb
- Recombinant
- KO Validated
- What is this?
4
(2 Reviews)
|
(11 Publications)
Rabbit Recombinant Monoclonal Peroxiredoxin 3/PRDX3 antibody. Suitable for IHC-P, IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 11 publications.
View Alternative Names
AOP1, PRDX3, Antioxidant protein 1, HBC189, Peroxiredoxin III, Peroxiredoxin-3, Protein MER5 homolog, Thioredoxin-dependent peroxiredoxin 3, AOP-1, Prx-III
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] (AB128953)
ab128953 at a 1/250 dilution staining Peroxiredoxin 3/PRDX3 in paraffin embedded Human liver tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] (AB128953)
Flow Cytometry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling Peroxiredoxin 3/PRDX3 with purified ab128953 at 1/1000 dilution (1 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] (AB128953)
ab128953 at a 1/250 dilution staining Peroxiredoxin 3/PRDX3 in paraffin embedded Human endometrium adenocarcinoma tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IP
Lab
Immunoprecipitation - Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] (AB128953)
Peroxiredoxin 3/PRDX3 was immunoprecipitated from 0.35 mg HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10 μg with ab128953 at 1/50 dilution (2μg). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10 μg
Lane 2 : ab128953 IP in HeLa whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab128953 in HeLa whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Upper bands could be ubiquitinated forms (PMID : 21795677)
All lanes:
Immunoprecipitation - Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] (ab128953)
Predicted band size: 28 kDa
Observed band size: 26 kDa
false
- WB
Lab
Western blot - Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] (AB128953)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : Peroxiredoxin 3/PRDX3 knockout HAP1 cell lysate (20 μg)
Lane 3 : MCF7 cell lysate (20 μg)
Lane 4 : A431 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab128953 observed at 24 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab128953 was shown to specifically react with Peroxiredoxin 3/PRDX3 in wild-type HAP1 cells. No band was observed when Peroxiredoxin 3/PRDX3 knockout samples were examined. Wild-type and Peroxiredoxin 3/PRDX3 knockout samples were subjected to SDS-PAGE. ab128953 and ab8245 (loading control to GAPDH) were both diluted 1/10,000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] (ab128953)
Predicted band size: 28 kDa
false
- WB
Unknown
Western blot - Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] (AB128953)
All lanes:
Western blot - Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] (ab128953) at 1/10000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
293T (Human embryonic kidney epithelial cell) cell lysate at 10 µg
Lane 3:
MCF7 cell lysate at 10 µg
Lane 4:
A431 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 28 kDa
Observed band size: 26 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] (AB128953)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-Peroxiredoxin 3/PRDX3 antibody [EPR8115] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzyme helps to safeguard cells from oxidative damage by reducing peroxides produced during cellular metabolism. PRDX3 participates in antioxidant defense mechanisms and may form functional complexes with other proteins to enhance its peroxidase activity. Its antioxidant properties contribute to the maintenance of mitochondrial integrity and influence cellular survival and apoptosis processes.
Pathways
PRDX3 integrates into the cellular antioxidant defense system prominently in the thioredoxin pathway. In this pathway PRDX3 synergizes with thioredoxin to neutralize harmful oxidative molecules. PRDX3's activity is interconnected with proteins such as thioredoxin and glutaredoxin which also partake in counteracting oxidative stress bolstering an organism's defense against cellular damage.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Archives of rheumatology 40:197-210 PubMed40757971
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 17: PubMed40647510
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 83:3931-3939.e5 PubMed37863053
2023
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasma 69:940-947 PubMed35723197
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2020:8291413 PubMed32774686
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32102467
2020
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 30:101417 PubMed31901729
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 129:2431-2445 PubMed31081803
2019
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federa 33:7863-7881 PubMed30939247
2019
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 128:1671-1687 PubMed29447131
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com